Is There an Alternative to Immediate Home Physical Therapy Following Total Knee Arthroplasty

May 11, 2023 updated by: Wolfgang Fitz, M.D.
The purpose of this study is to evaluate how different pre-operative therapeutic approaches affect quad strength and patient satisfaction after total knee replacements. There are three treatments groups: standard physical therapy protocol, the use of CyMedica NMES garments, and a telemedical home therapy program.

Study Overview

Detailed Description

Patients undergoing total knee replacement (TKR) at Brigham and Women's Faulkner Hospital and meet all eligibility criteria will be informed about the study and asked if they would like to participate. The research assistant (RA) will screen upcoming surgeries and call all qualifying patients to inform them of the study. Those who show interest will be offered the opportunity to discuss with both the RA and Principal Investigator (PI). Upon agreement, the patient's consent will be obtained and they will be randomly assigned to one of three treatment groups using a computer-generated randomization.

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02130
        • Brigham and Women's Faulkner Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 18 or older
  • Owns a device with internet connection
  • Can download the E-vive application for the contractile garment (has sufficiently up-to-date phone or tablet, or has family member with such a device).
  • Has a rudimentary understanding of Internet technology, especially e-mail
  • Has a flexion of 90 o and flexion contracture of 5 o at the point of discharge
  • Approved by a physical therapist to participate safely in the study at the time of discharge

Exclusion Criteria:

  • Rheumatoid arthritis
  • History of epilepsy
  • Implanted and body-worn electronic medical device, including cardiac pacemakers, neural stimulators, insulin pumps, etc.
  • Poor understanding of the use of the brace/electrical stimulation
  • Lesions on the skin over the thigh
  • Uncontrolled diabetes
  • Uncontrolled hypertension
  • Bilateral TKA or UKA planned
  • If female, pregnant
  • Cannot use non-operated leg postoperatively to propel active motion splint, caused by neurological or muscular diseases such as complete or incomplete paralysis or other causes of weakness with an inability to bend or extend knee
  • Loss of sensation in operated or non-operated leg
  • Has below- or above-knee amputations of non-operative leg
  • Below- knee amputation of operated side
  • Chronic pain syndrome with inability to walk
  • Taking chronic narcotics and/or is taking more than 10mg codeine per day, or any Hydrocodone, or more than 200 mg of tramadol, or any other narcotics prescribed for moderate to severe pain
  • Involved in pain clinics for chronic pain, or pain that is not related to the knee
  • Has been diagnosed with knee disorder other than osteoarthritis, post-traumatic osteoarthritis, gout, pseudo gout, or any inability to walk due to disorders unrelated to the knee (e.g., hip disorders, spinal stenosis, paralysis, hemi-paralysis)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group 1, iGetBetter Group
Use only iGetBetter for the 3 months preceding surgery. After surgery, you will be given a new, Post-Op program to use for 2-3 months. For the first 3 weeks, you will only use iGetBetter. After those 3 weeks, you will receive outpatient physical therapy in addition to iGetBetter, approximately twice per week for the next 6-8 weeks.
Group 1 patients will only use a Post-Op program from iGetBetter for the first 3 weeks after surgery. After those 3 weeks have elapsed, Group 1 patients will receive outpatient physical therapy in addition to iGetBetter, approximately twice per week for the next 6-8 weeks as all other groups.
Experimental: Group 2, E-vive Group
You will use iGetBetter starting 3 months out from surgery. You will receive CyMedica's electrical-stimulation garment during the preoperative appointment. In addition to iGetBetter, you will wear the conductive garment two times each day for the last 3 weeks before surgery. After surgery, for the first 3 weeks you will only use the conductive garment, and will not use iGetBetter. After those 3 weeks, you will receive outpatient physical therapy in addition to wearing the brace, approximately twice per week for the next 6-8 weeks. You will not need to return the brace after this time is up, and you may keep the brace, if you so choose, at no cost.

All the patients in Group 2 will be given the CyMedica Orthopedics e-vive system 3 weeks before the surgery. The patients will begin using the unit after their first pre-intervention measurements are taken.

Patients will be instructed to apply the e-vive NMES Strength therapy twice a day, 5 days a week. The NMES Strength program is 20 minutes in length. Treatment intensity (adjustable from 1 to 100 in NMES programs) is required to be set at the highest tolerable limit for the patients.

Stimulation from the garment will have the following parameters: frequency of 50 Hz; pulse duration of 5 ms; time on: 12.8 seconds; and time off: 10 seconds. The total contraction time in a 20-minute treatment will be 11 minutes. The waveform will be pulsed and asymmetrical.

Other Names:
  • Powered Muscle Stimulator or Neuromuscular Electrical Stimulator (NMES); IPF Transcutaneous Nerve Stimulator (TENS) for pain relief; GZJ Goniometer; KQX
No Intervention: Group 3, Physical Therapy Group
You will receive only iGetBetter for the 3 months preceding surgery. After surgery, you will receive only home physical therapy, and will not use iGetBetter. After those three weeks, you will receive outpatient physical therapy approximately twice per week for the next 6-8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quadriceps Strength
Time Frame: Preoperative and postoperative appointments (2 months after surgery)
Change in quadriceps strength in lbs of force, as measured by PT dynamometer
Preoperative and postoperative appointments (2 months after surgery)
Balancing
Time Frame: Preoperative and postoperative appointments (2 months after surgery)
Change in proprioception (balance) as measured by 30-second single limb stance PT test
Preoperative and postoperative appointments (2 months after surgery)
Sit-to-stand Time
Time Frame: Preoperative (varies) and postoperative appointments (2 months after surgery)
Change in sit-to-stand capabilities
Preoperative (varies) and postoperative appointments (2 months after surgery)
2 Minute Walking Time
Time Frame: Preoperative and postoperative appointments (2 months after surgery)
Change in distance walked in 2 minutes
Preoperative and postoperative appointments (2 months after surgery)
Walking Speed
Time Frame: Preoperative and postoperative appointments (2 months after surgery)
Change in walking speed
Preoperative and postoperative appointments (2 months after surgery)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale (VAS) Pain
Time Frame: first postoperative months (from days post-op through 2-month post-operative appointment)
Change in Visual Analog Scale for pain (1-10) 1 no pain 10 worse
first postoperative months (from days post-op through 2-month post-operative appointment)
Visual Analogue Scale (VAS) Nausea
Time Frame: first postoperative months (from days post-op through 2-month post-operative appointment)
Change in VAS nausea (Visual Analog Scale for nausea (1-10) 1 no nausea 10 worse nausea )
first postoperative months (from days post-op through 2-month post-operative appointment)
Visual Analogue Scale (VAS) Satisfaction
Time Frame: first postoperative months (from days post-op through 2-month post-operative appointment)
Change in VAS satisfaction (Visual Analog Scale for satisfaction (1-10) 1 not satisfied, 10 totally unsatisfied)
first postoperative months (from days post-op through 2-month post-operative appointment)
Readmission Rate
Time Frame: Noted by PI at 2nd postoperative appointment (about 10 weeks after surgery)
major complication
Noted by PI at 2nd postoperative appointment (about 10 weeks after surgery)
Infection Rate
Time Frame: Noted by PI at 2nd postoperative appointment (about 10 weeks after surgery)
superficial and deep infection
Noted by PI at 2nd postoperative appointment (about 10 weeks after surgery)
Cost Per Treatment Regimen (iGetBetter vs. CyMedica E-vive vs. Home PT)
Time Frame: Completion of study (anticipate one year from start data 4/4/2019)
We will calculate the total cost of each treatment modality
Completion of study (anticipate one year from start data 4/4/2019)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wolfgang Fitz, MD, Brigham and Women's Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 4, 2019

Primary Completion (Actual)

January 17, 2022

Study Completion (Actual)

January 17, 2022

Study Registration Dates

First Submitted

April 3, 2019

First Submitted That Met QC Criteria

August 14, 2019

First Posted (Actual)

August 19, 2019

Study Record Updates

Last Update Posted (Actual)

June 7, 2023

Last Update Submitted That Met QC Criteria

May 11, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No IPD will be shared with other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Knee Arthroplasty

Clinical Trials on iGetBetter telemedicine physical therapy

3
Subscribe